Global T-Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global T-Cell Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The Global Info Research report includes an overview of the development of the T-Cell Therapy industry chain, the market status of Hospitals (CAR T Cell Therapy, TCR Therapy), Clinics & Ambulatory Centers (CAR T Cell Therapy, TCR Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of T-Cell Therapy.

Regionally, the report analyzes the T-Cell Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global T-Cell Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the T-Cell Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the T-Cell Therapy industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., CAR T Cell Therapy, TCR Therapy).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the T-Cell Therapy market.

Regional Analysis: The report involves examining the T-Cell Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the T-Cell Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to T-Cell Therapy:
Company Analysis: Report covers individual T-Cell Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards T-Cell Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics & Ambulatory Centers).

Technology Analysis: Report covers specific technologies relevant to T-Cell Therapy. It assesses the current state, advancements, and potential future developments in T-Cell Therapy areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the T-Cell Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
T-Cell Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    CAR T Cell Therapy
    TCR Therapy
    TIL Therapy

Market segment by Application
    Hospitals
    Clinics & Ambulatory Centers
    Cancer Research Institutes
    Others

Market segment by players, this report covers
    Gilead Sciences, Inc.
    Sorrento Therapeutics
    Fate Therapeutics Inc.
    Novartis International AG
    AbbVie Inc.
    Adaptimmune Therapeutics PLC
    Bluebird Bio
    TCR2 Therapeutics, Inc.
    Pfizer Inc.
    DiaCarta, Inc.

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe T-Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of T-Cell Therapy, with revenue, gross margin and global market share of T-Cell Therapy from 2019 to 2024.
Chapter 3, the T-Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and T-Cell Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of T-Cell Therapy.
Chapter 13, to describe T-Cell Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of T-Cell Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of T-Cell Therapy by Type
        1.3.1 Overview: Global T-Cell Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global T-Cell Therapy Consumption Value Market Share by Type in 2023
        1.3.3 CAR T Cell Therapy
        1.3.4 TCR Therapy
        1.3.5 TIL Therapy
    1.4 Global T-Cell Therapy Market by Application
        1.4.1 Overview: Global T-Cell Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospitals
        1.4.3 Clinics & Ambulatory Centers
        1.4.4 Cancer Research Institutes
        1.4.5 Others
    1.5 Global T-Cell Therapy Market Size & Forecast
    1.6 Global T-Cell Therapy Market Size and Forecast by Region
        1.6.1 Global T-Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global T-Cell Therapy Market Size by Region, (2019-2030)
        1.6.3 North America T-Cell Therapy Market Size and Prospect (2019-2030)
        1.6.4 Europe T-Cell Therapy Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific T-Cell Therapy Market Size and Prospect (2019-2030)
        1.6.6 South America T-Cell Therapy Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa T-Cell Therapy Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Gilead Sciences, Inc.
        2.1.1 Gilead Sciences, Inc. Details
        2.1.2 Gilead Sciences, Inc. Major Business
        2.1.3 Gilead Sciences, Inc. T-Cell Therapy Product and Solutions
        2.1.4 Gilead Sciences, Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Gilead Sciences, Inc. Recent Developments and Future Plans
    2.2 Sorrento Therapeutics
        2.2.1 Sorrento Therapeutics Details
        2.2.2 Sorrento Therapeutics Major Business
        2.2.3 Sorrento Therapeutics T-Cell Therapy Product and Solutions
        2.2.4 Sorrento Therapeutics T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Sorrento Therapeutics Recent Developments and Future Plans
    2.3 Fate Therapeutics Inc.
        2.3.1 Fate Therapeutics Inc. Details
        2.3.2 Fate Therapeutics Inc. Major Business
        2.3.3 Fate Therapeutics Inc. T-Cell Therapy Product and Solutions
        2.3.4 Fate Therapeutics Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Fate Therapeutics Inc. Recent Developments and Future Plans
    2.4 Novartis International AG
        2.4.1 Novartis International AG Details
        2.4.2 Novartis International AG Major Business
        2.4.3 Novartis International AG T-Cell Therapy Product and Solutions
        2.4.4 Novartis International AG T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Novartis International AG Recent Developments and Future Plans
    2.5 AbbVie Inc.
        2.5.1 AbbVie Inc. Details
        2.5.2 AbbVie Inc. Major Business
        2.5.3 AbbVie Inc. T-Cell Therapy Product and Solutions
        2.5.4 AbbVie Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 AbbVie Inc. Recent Developments and Future Plans
    2.6 Adaptimmune Therapeutics PLC
        2.6.1 Adaptimmune Therapeutics PLC Details
        2.6.2 Adaptimmune Therapeutics PLC Major Business
        2.6.3 Adaptimmune Therapeutics PLC T-Cell Therapy Product and Solutions
        2.6.4 Adaptimmune Therapeutics PLC T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Adaptimmune Therapeutics PLC Recent Developments and Future Plans
    2.7 Bluebird Bio
        2.7.1 Bluebird Bio Details
        2.7.2 Bluebird Bio Major Business
        2.7.3 Bluebird Bio T-Cell Therapy Product and Solutions
        2.7.4 Bluebird Bio T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Bluebird Bio Recent Developments and Future Plans
    2.8 TCR2 Therapeutics, Inc.
        2.8.1 TCR2 Therapeutics, Inc. Details
        2.8.2 TCR2 Therapeutics, Inc. Major Business
        2.8.3 TCR2 Therapeutics, Inc. T-Cell Therapy Product and Solutions
        2.8.4 TCR2 Therapeutics, Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 TCR2 Therapeutics, Inc. Recent Developments and Future Plans
    2.9 Pfizer Inc.
        2.9.1 Pfizer Inc. Details
        2.9.2 Pfizer Inc. Major Business
        2.9.3 Pfizer Inc. T-Cell Therapy Product and Solutions
        2.9.4 Pfizer Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Pfizer Inc. Recent Developments and Future Plans
    2.10 DiaCarta, Inc.
        2.10.1 DiaCarta, Inc. Details
        2.10.2 DiaCarta, Inc. Major Business
        2.10.3 DiaCarta, Inc. T-Cell Therapy Product and Solutions
        2.10.4 DiaCarta, Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 DiaCarta, Inc. Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global T-Cell Therapy Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of T-Cell Therapy by Company Revenue
        3.2.2 Top 3 T-Cell Therapy Players Market Share in 2023
        3.2.3 Top 6 T-Cell Therapy Players Market Share in 2023
    3.3 T-Cell Therapy Market: Overall Company Footprint Analysis
        3.3.1 T-Cell Therapy Market: Region Footprint
        3.3.2 T-Cell Therapy Market: Company Product Type Footprint
        3.3.3 T-Cell Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global T-Cell Therapy Consumption Value and Market Share by Type (2019-2024)
    4.2 Global T-Cell Therapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global T-Cell Therapy Consumption Value Market Share by Application (2019-2024)
    5.2 Global T-Cell Therapy Market Forecast by Application (2025-2030)

6 North America
    6.1 North America T-Cell Therapy Consumption Value by Type (2019-2030)
    6.2 North America T-Cell Therapy Consumption Value by Application (2019-2030)
    6.3 North America T-Cell Therapy Market Size by Country
        6.3.1 North America T-Cell Therapy Consumption Value by Country (2019-2030)
        6.3.2 United States T-Cell Therapy Market Size and Forecast (2019-2030)
        6.3.3 Canada T-Cell Therapy Market Size and Forecast (2019-2030)
        6.3.4 Mexico T-Cell Therapy Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe T-Cell Therapy Consumption Value by Type (2019-2030)
    7.2 Europe T-Cell Therapy Consumption Value by Application (2019-2030)
    7.3 Europe T-Cell Therapy Market Size by Country
        7.3.1 Europe T-Cell Therapy Consumption Value by Country (2019-2030)
        7.3.2 Germany T-Cell Therapy Market Size and Forecast (2019-2030)
        7.3.3 France T-Cell Therapy Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom T-Cell Therapy Market Size and Forecast (2019-2030)
        7.3.5 Russia T-Cell Therapy Market Size and Forecast (2019-2030)
        7.3.6 Italy T-Cell Therapy Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific T-Cell Therapy Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific T-Cell Therapy Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific T-Cell Therapy Market Size by Region
        8.3.1 Asia-Pacific T-Cell Therapy Consumption Value by Region (2019-2030)
        8.3.2 China T-Cell Therapy Market Size and Forecast (2019-2030)
        8.3.3 Japan T-Cell Therapy Market Size and Forecast (2019-2030)
        8.3.4 South Korea T-Cell Therapy Market Size and Forecast (2019-2030)
        8.3.5 India T-Cell Therapy Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia T-Cell Therapy Market Size and Forecast (2019-2030)
        8.3.7 Australia T-Cell Therapy Market Size and Forecast (2019-2030)

9 South America
    9.1 South America T-Cell Therapy Consumption Value by Type (2019-2030)
    9.2 South America T-Cell Therapy Consumption Value by Application (2019-2030)
    9.3 South America T-Cell Therapy Market Size by Country
        9.3.1 South America T-Cell Therapy Consumption Value by Country (2019-2030)
        9.3.2 Brazil T-Cell Therapy Market Size and Forecast (2019-2030)
        9.3.3 Argentina T-Cell Therapy Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa T-Cell Therapy Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa T-Cell Therapy Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa T-Cell Therapy Market Size by Country
        10.3.1 Middle East & Africa T-Cell Therapy Consumption Value by Country (2019-2030)
        10.3.2 Turkey T-Cell Therapy Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia T-Cell Therapy Market Size and Forecast (2019-2030)
        10.3.4 UAE T-Cell Therapy Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 T-Cell Therapy Market Drivers
    11.2 T-Cell Therapy Market Restraints
    11.3 T-Cell Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 T-Cell Therapy Industry Chain
    12.2 T-Cell Therapy Upstream Analysis
    12.3 T-Cell Therapy Midstream Analysis
    12.4 T-Cell Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global T-Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global T-Cell Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global T-Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global T-Cell Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Gilead Sciences, Inc. Company Information, Head Office, and Major Competitors
    Table 6. Gilead Sciences, Inc. Major Business
    Table 7. Gilead Sciences, Inc. T-Cell Therapy Product and Solutions
    Table 8. Gilead Sciences, Inc. T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Gilead Sciences, Inc. Recent Developments and Future Plans
    Table 10. Sorrento Therapeutics Company Information, Head Office, and Major Competitors
    Table 11. Sorrento Therapeutics Major Business
    Table 12. Sorrento Therapeutics T-Cell Therapy Product and Solutions
    Table 13. Sorrento Therapeutics T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Sorrento Therapeutics Recent Developments and Future Plans
    Table 15. Fate Therapeutics Inc. Company Information, Head Office, and Major Competitors
    Table 16. Fate Therapeutics Inc. Major Business
    Table 17. Fate Therapeutics Inc. T-Cell Therapy Product and Solutions
    Table 18. Fate Therapeutics Inc. T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Fate Therapeutics Inc. Recent Developments and Future Plans
    Table 20. Novartis International AG Company Information, Head Office, and Major Competitors
    Table 21. Novartis International AG Major Business
    Table 22. Novartis International AG T-Cell Therapy Product and Solutions
    Table 23. Novartis International AG T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Novartis International AG Recent Developments and Future Plans
    Table 25. AbbVie Inc. Company Information, Head Office, and Major Competitors
    Table 26. AbbVie Inc. Major Business
    Table 27. AbbVie Inc. T-Cell Therapy Product and Solutions
    Table 28. AbbVie Inc. T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. AbbVie Inc. Recent Developments and Future Plans
    Table 30. Adaptimmune Therapeutics PLC Company Information, Head Office, and Major Competitors
    Table 31. Adaptimmune Therapeutics PLC Major Business
    Table 32. Adaptimmune Therapeutics PLC T-Cell Therapy Product and Solutions
    Table 33. Adaptimmune Therapeutics PLC T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Adaptimmune Therapeutics PLC Recent Developments and Future Plans
    Table 35. Bluebird Bio Company Information, Head Office, and Major Competitors
    Table 36. Bluebird Bio Major Business
    Table 37. Bluebird Bio T-Cell Therapy Product and Solutions
    Table 38. Bluebird Bio T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Bluebird Bio Recent Developments and Future Plans
    Table 40. TCR2 Therapeutics, Inc. Company Information, Head Office, and Major Competitors
    Table 41. TCR2 Therapeutics, Inc. Major Business
    Table 42. TCR2 Therapeutics, Inc. T-Cell Therapy Product and Solutions
    Table 43. TCR2 Therapeutics, Inc. T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. TCR2 Therapeutics, Inc. Recent Developments and Future Plans
    Table 45. Pfizer Inc. Company Information, Head Office, and Major Competitors
    Table 46. Pfizer Inc. Major Business
    Table 47. Pfizer Inc. T-Cell Therapy Product and Solutions
    Table 48. Pfizer Inc. T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Pfizer Inc. Recent Developments and Future Plans
    Table 50. DiaCarta, Inc. Company Information, Head Office, and Major Competitors
    Table 51. DiaCarta, Inc. Major Business
    Table 52. DiaCarta, Inc. T-Cell Therapy Product and Solutions
    Table 53. DiaCarta, Inc. T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. DiaCarta, Inc. Recent Developments and Future Plans
    Table 55. Global T-Cell Therapy Revenue (USD Million) by Players (2019-2024)
    Table 56. Global T-Cell Therapy Revenue Share by Players (2019-2024)
    Table 57. Breakdown of T-Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 58. Market Position of Players in T-Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 59. Head Office of Key T-Cell Therapy Players
    Table 60. T-Cell Therapy Market: Company Product Type Footprint
    Table 61. T-Cell Therapy Market: Company Product Application Footprint
    Table 62. T-Cell Therapy New Market Entrants and Barriers to Market Entry
    Table 63. T-Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 64. Global T-Cell Therapy Consumption Value (USD Million) by Type (2019-2024)
    Table 65. Global T-Cell Therapy Consumption Value Share by Type (2019-2024)
    Table 66. Global T-Cell Therapy Consumption Value Forecast by Type (2025-2030)
    Table 67. Global T-Cell Therapy Consumption Value by Application (2019-2024)
    Table 68. Global T-Cell Therapy Consumption Value Forecast by Application (2025-2030)
    Table 69. North America T-Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 70. North America T-Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 71. North America T-Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 72. North America T-Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 73. North America T-Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 74. North America T-Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 75. Europe T-Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 76. Europe T-Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 77. Europe T-Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 78. Europe T-Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 79. Europe T-Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 80. Europe T-Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 81. Asia-Pacific T-Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 82. Asia-Pacific T-Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 83. Asia-Pacific T-Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 84. Asia-Pacific T-Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 85. Asia-Pacific T-Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 86. Asia-Pacific T-Cell Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 87. South America T-Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 88. South America T-Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 89. South America T-Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 90. South America T-Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 91. South America T-Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 92. South America T-Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 93. Middle East & Africa T-Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 94. Middle East & Africa T-Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 95. Middle East & Africa T-Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 96. Middle East & Africa T-Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 97. Middle East & Africa T-Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 98. Middle East & Africa T-Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 99. T-Cell Therapy Raw Material
    Table 100. Key Suppliers of T-Cell Therapy Raw Materials
List of Figures
    Figure 1. T-Cell Therapy Picture
    Figure 2. Global T-Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global T-Cell Therapy Consumption Value Market Share by Type in 2023
    Figure 4. CAR T Cell Therapy
    Figure 5. TCR Therapy
    Figure 6. TIL Therapy
    Figure 7. Global T-Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 8. T-Cell Therapy Consumption Value Market Share by Application in 2023
    Figure 9. Hospitals Picture
    Figure 10. Clinics & Ambulatory Centers Picture
    Figure 11. Cancer Research Institutes Picture
    Figure 12. Others Picture
    Figure 13. Global T-Cell Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 14. Global T-Cell Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 15. Global Market T-Cell Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 16. Global T-Cell Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 17. Global T-Cell Therapy Consumption Value Market Share by Region in 2023
    Figure 18. North America T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 20. Asia-Pacific T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 21. South America T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 22. Middle East and Africa T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 23. Global T-Cell Therapy Revenue Share by Players in 2023
    Figure 24. T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 25. Global Top 3 Players T-Cell Therapy Market Share in 2023
    Figure 26. Global Top 6 Players T-Cell Therapy Market Share in 2023
    Figure 27. Global T-Cell Therapy Consumption Value Share by Type (2019-2024)
    Figure 28. Global T-Cell Therapy Market Share Forecast by Type (2025-2030)
    Figure 29. Global T-Cell Therapy Consumption Value Share by Application (2019-2024)
    Figure 30. Global T-Cell Therapy Market Share Forecast by Application (2025-2030)
    Figure 31. North America T-Cell Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 32. North America T-Cell Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 33. North America T-Cell Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 34. United States T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 35. Canada T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 36. Mexico T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 37. Europe T-Cell Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 38. Europe T-Cell Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 39. Europe T-Cell Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 40. Germany T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 41. France T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 42. United Kingdom T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 43. Russia T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 44. Italy T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 45. Asia-Pacific T-Cell Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 46. Asia-Pacific T-Cell Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 47. Asia-Pacific T-Cell Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 48. China T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 49. Japan T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 50. South Korea T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 51. India T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 52. Southeast Asia T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 53. Australia T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 54. South America T-Cell Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 55. South America T-Cell Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 56. South America T-Cell Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 57. Brazil T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 58. Argentina T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 59. Middle East and Africa T-Cell Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 60. Middle East and Africa T-Cell Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 61. Middle East and Africa T-Cell Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 62. Turkey T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 63. Saudi Arabia T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 64. UAE T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 65. T-Cell Therapy Market Drivers
    Figure 66. T-Cell Therapy Market Restraints
    Figure 67. T-Cell Therapy Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of T-Cell Therapy in 2023
    Figure 70. Manufacturing Process Analysis of T-Cell Therapy
    Figure 71. T-Cell Therapy Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source

Companies Mentioned

Gilead Sciences, Inc.
Sorrento Therapeutics
Fate Therapeutics Inc.
Novartis International AG
AbbVie Inc.
Adaptimmune Therapeutics PLC
Bluebird Bio
TCR2 Therapeutics, Inc.
Pfizer Inc.
DiaCarta, Inc.